These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2160194)

  • 1. Gestational trophoblastic disease: what have we learned in the past decade?
    Jones WB
    Am J Obstet Gynecol; 1990 May; 162(5):1286-95. PubMed ID: 2160194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
    Luschin-Ebengreuth G; Petru E; Pickel H
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():125-6. PubMed ID: 1337488
    [No Abstract]   [Full Text] [Related]  

  • 3. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor.
    Lage JM; Berkowitz RS; Rice LW; Goldstein DP; Bernstein MR; Weinberg DS
    Obstet Gynecol; 1991 Jan; 77(1):111-5. PubMed ID: 1845777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The syndrome of partial mole.
    Wong LC; Ma HK
    Arch Gynecol; 1984; 234(3):161-6. PubMed ID: 6203492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in gestational trophoblastic disease.
    Schorge JO; Goldstein DP; Bernstein MR; Berkowitz RS
    J Reprod Med; 2000 Sep; 45(9):692-700. PubMed ID: 11027078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic studies on hydatidiform moles.
    Lawler SD
    Adv Exp Med Biol; 1984; 176():147-61. PubMed ID: 6388257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial hydatidiform moles: a review.
    Watson EJ; Hernandez E; Miyazawa K
    Obstet Gynecol Surv; 1987 Sep; 42(9):540-4. PubMed ID: 2443883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective genetic study of complete and partial hydatidiform moles.
    Lawler SD; Fisher RA; Dent J
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1270-7. PubMed ID: 1674641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gestational trophoblastic tumors and recent clinical information].
    Shimizu T; Yaegashi N
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic profile of gestational trophoblastic disease.
    Jelincic D; Hudelist G; Singer CF; Bauer M; Horn LC; Bilek K; Czerwenka K
    Wien Klin Wochenschr; 2003 Jan; 115(1-2):29-35. PubMed ID: 12658908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-erbB-2 amplification and expression in gestational trophoblastic disease correlates with DNA content and karyotype.
    Bauer M; Horn LC; Kowalzik J; Mair W; Czerwenka K
    Gen Diagn Pathol; 1997 Nov; 143(2-3):185-90. PubMed ID: 9443575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmolar trophoblastic disease: diagnosis, management, and prognosis.
    Morrow CP
    Clin Obstet Gynecol; 1984 Mar; 27(1):211-20. PubMed ID: 6323079
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy.
    Gillespie AM; Kumar S; Hancock BW
    Br J Cancer; 2000 Apr; 82(8):1393-5. PubMed ID: 10780516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dispermic origin and clinical outcome of three complete hydatidiform moles with 46,XY karyotype.
    Surti U; Szulman AE; O'Brien S
    Am J Obstet Gynecol; 1982 Sep; 144(1):84-7. PubMed ID: 7114116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.